A tricyclic indazole compound of general formula: where Y is CH or N; W is CH or N; provided that at least one of Y and W is a nitrogen atom; X 1 and X 3 can be independently a σ bond, a divalent alkyl chain containing from 1 to 5 carbon atoms, a carbonyl group, a divalent alkanoyl chain of the type -CO-(CH 2) 1-4 - or -(CH 2) 1-4 -CO-, wherein the hydrogen atoms of said alkyl and alkanoyl chains can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups; X 4 can be a divalent alkyl chain containing from 1 to 5 carbon atoms, a carbonyl group, a divalent alkanoyl chain of the type -CO-(CH 2) 1-4 - or -(CH 2) 1-4 -CO-, wherein the hydrogen atoms of said alkyl and alkanoyl chains can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups; X 2 and X 5 can be independently a σ bond or a divalent alkyl chain containing from 1 to 4 carbon atoms, wherein the hydrogen atoms of said alkyl chain can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups, and at least one of X 2 and X 5 is different from σ bond; L 1 and L 2 can be independently a σ bond or a π bond; R 1 can be independently H, OH, halogen, CN, C 1-3 alkyl, C 1-3 alkoxy, NR i R ii, NO 2, CF 3, CONR iii R iv, SO 2 R v, OCF 3, N(R vi)SO 2 R vii, C(NR viii)N(R ix R x), N(R xi)C R xii; R 2 can be independently H, OH, halogen, CN, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 hydroxyalkyl, C 1-3 aminoalkyl, NR i R ii, NO 2, CF 3, CONR iii R iv, SO 2 R v, OCF 3, N(R vi)SO 2 R vii, C(NR viii)N(R ix R x), N(R xi)C R xii; m and n can be independently from 1 to 3; R i, R ii, R iii, R iv, R v, R vi, R vii, R viii, R ix, R x, R xi, R xii can be independently H or C 1-3 alkyl; and its salts of addition with pharmaceutically acceptable organic and inorganic acids. Y is CH or N; W is CH or N; provided that at least one of Y and W is a nitrogen atom; X 1 and X 3 can be independently a σ bond, a divalent alkyl chain containing from 1 to 5 carbon atoms, a carbonyl group, a divalent alkanoyl chain of the type -CO-(CH 2) 1-4 - or -(CH 2) 1-4 -CO-, wherein the hydrogen atoms of said alkyl and alkanoyl chains can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups; X 4 can be a divalent alkyl chain containing from 1 to 5 carbon atoms, a carbonyl group, a divalent alkanoyl chain of the type -CO-(CH 2) 1-4 - or -(CH 2) 1-4 -CO-, wherein the hydrogen atoms of said alkyl and alkanoyl chains can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups; X 2 and X 5 can be independently a σ bond or a divalent alkyl chain containing from 1 to 4 carbon atoms, wherein the hydrogen atoms of said alkyl chain can be optionally substituted with one or more halogen atoms, one or more C 1-3 alkyl groups, one or more C 1-3 alkoxy groups, and at least one of X 2 and X 5 is different from σ bond; L 1 and L 2 can be independently a σ bond or a π bond; R 1 can be independently H, OH, halogen, CN, C 1-3 alkyl, C 1-3 alkoxy, NR i R ii, NO 2, CF 3, CONR iii R iv, SO 2 R v, OCF 3, N(R vi)SO 2 R vii, C(NR viii)N(R ix R x), N(R xi)C R xii; R 2 can be independently H, OH, halogen, CN, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 hydroxyalkyl, C 1-3 aminoalkyl, NR i R ii, NO 2, CF 3, CONR iii R iv, SO 2 R v, OCF 3, N(R vi)SO 2 R vii, C(NR viii)N(R ix R x), N(R xi)C R xii; m and n can be independently from 1 to 3; R i, R ii, R iii, R iv, R v, R vi, R vii, R viii, R ix, R x, R xi, R xii can be independently H or C 1-3 alkyl; and its salts of addition with pharmaceutically acceptable organic and inorganic acids.